China NT Pharma Group Co., Ltd. (1011)
Market Closed
30 Sep, 08:00 AM
HKEX HKEX Primary 0. 41
HKD 0
0%
552.88M Market Cap
- P/E Ratio
- Div Yield
660,000 Volume
- Eps
0.41 HKD
Previous Close Want to track 1011 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
China NT Pharma Group Co., Ltd. (1011) Statistics
Valuation metrics
Market Cap 552.88M
Enterprise value 490.52M
Trailing P/E (ttm) -7.17
Forward P/E 5.55
PEG ratio -0.06
Price/Sales (ttm) 4.72
Price/Book (mrq) -1.88
Enterprise Value/Revenue 13.82
Enterprise Value/EBITDA -38.02
Overview
Shares outstanding 674.25M
Float 136.05M
Shares short -
% Held by insiders 0.85%
% Held by institutions -
Average volume (10 days) 5K
Average volume (90 days) 255.68K
Price summary
52-Week low 0.3
52-Week high 1.19
Beta -1.97
50-Day moving average 0.4
200-Day moving average 0.48
Dividends and splits
Forward annual dividend rate 1.4
Forward annual dividend yield 2.2951%
Trailing annual dividend rate 0.35
Trailing annual dividend yield 0.5738%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Jul 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2018
Profitability
Profit margin -0.77%
Operating margin -0.39%
Operational effectiveness
Return on assets -0.04%
Return on equity 0.14%
Income Statement
Revenue (ttm) 27.79M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 0.82%
Gross profit (ttm) 11.05M
EBITDA -14.17M
Net income to common (ttm) -29.96M
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.31M
Total cash per share (mrq) 0.01
Total debt (mrq) 364.31M
Total Debt/Equity (mrq) -3.01
Current ratio (mrq) 0.05%
Book value per share (mrq) -0.06
Cash Flow
Cash flow statement 203K
Levered free cash flow (LFCF) -26.04M
2026 © Marketlog. All Rights Reserved.
